Boston Scientific (BSX) Granted FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate Devices
September 25, 2017 7:04 AM
Boston Scientific (NYSE: BSX) has launched the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
